Internal Medicine in Willowbrook, IL
9 verified internal medicine doctors in Willowbrook.
Internists specialize in the prevention, diagnosis, and treatment of adult diseases, often coordinating complex or chronic conditions across multiple systems.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Illinois Dept. of Financial & Professional Regulation
Dr. Daniel Grzegorek, DO
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Muhammad Ali, MD
Internal Medicine
CMS Open Payments· $334.38 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$334.38
Total received
10
Transactions
4
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Muhammad Ali do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shirley Stilson, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Rathna Yallapragada, MD
Internal Medicine
CMS Open Payments· $109,163 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$109,163
Total received
123
Transactions
7
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Rathna Yallapragada do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Anthony Delorenzo, DO
Internal Medicine
CMS Open Payments· $1,223 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,223
Total received
54
Transactions
14
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Anthony Delorenzo do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Roland Borrasi, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. John Ibrahim, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Gjulshana Nurceski, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alma Gonzalez, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.